Document is current
Any future updates will be listed below
-
Authors
Cui, Haotian https://orcid.org/0000-0001-8119-9485
Wang, Chloe
Maan, Hassaan https://orcid.org/0000-0002-3830-7177
Pang, Kuan https://orcid.org/0000-0003-3338-1738
Luo, Fengning
Duan, Nan https://orcid.org/0000-0002-3387-4674
-
Funding
Funding for this research was provided by:
Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (RGPIN-2020-06189, DGECR-2020-00294, Doctoral Fellowship)
University Health Network (Peter Munk Cardiac Centre AI Fund)
The AI Chairs Program funded by CIFAR, which is the Canadian Institute for Advanced Research, website at https://cifar.ca/
- License Information
-
More Information
Article History
Received: 12 July 2023
Accepted: 30 January 2024
First Online: 26 February 2024
Competing interests
: B.W. is on the advisory board of Vevo Therapeutics. N.D. is an employee of Microsoft and holds equity in the company. The remaining authors declare no competing interests.
